nach oben

Rheumatology International

Erschienen in:

22.12.2017 | Systematic Review

Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview

verfasst von: Dan Xing, Qi Wang, Ziyi Yang, Yunfei Hou, Wei Zhang, Yaolong Chen, Jianhao Lin

Erschienen in: Rheumatology International | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Numerous systematic reviews investigating the effects of mesenchymal stem cells (MSCs) in treating knee osteoarthritis (OA) have been published with controversial conclusion. The purpose of the overview was (1) to perform an overview of systematic reviews investigating MSCs for knee OA and (2) to synthesize evidence qualitatively to assess confidence in the review findings. A systematic search of systematic reviews published through Aug 2017 was conducted using the MEDLINE, EMBASE and Cochrane Library. The methodological quality and risk of bias of included systematic reviews was assessed by AMSTAR instrument and ROBIS tool, respectively. Best evidence choice procedure was conducted according to the Jadad decision algorithm. The systematic reviews with high methodological quality and low risk of bias were selected ultimately for further evidence synthesis based on the CERQual tool. Four systematic reviews were eligible for inclusion. According to the ROBIS tool, there was one systematic review with low risk of bias and three with high risk of bias. Thus, only one systematic review conducted by Pas et al. with highest AMSTAR score and low risk of bias was selected. For all outcomes after evidence synthesis via the CERQual tool, confidence for decision making was either low (self-reported measurement and MRI/histological outcome) or moderate (adverse events). The present study demonstrates that moderate confidence could be placed in safety of MSCs therapy for knee OA, but with low confidence in efficacy outcomes due to limitations of the current evidence. Further high-quality studies with high internal and external validity are still required.

Nur mit Berechtigung zugänglich

Sacks JJ, Luo YH, Helmick CG (2010) Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001–2005. Arthritis Care Res (Hoboken) 62(4):460–464CrossRef

Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58(1):26–35PubMedPubMedCentralCrossRef

Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25PubMedCrossRef

Kane P, Frederick R, Tucker B et al (2013) Surgical restoration/repair of articular cartilage injuries in athletes. Phys Sportsmed 41:75–86PubMedCrossRef

Nyvang J, Hedström M, Gleissman SA (2016) It’s not just a knee, but a whole life: a qualitative descriptive study on patients’ experiences of living with knee osteoarthritis and their expectations for knee arthroplasty. Int J Qual Stud Health Well-being 11:30193PubMedCrossRef

Crawford DC, Miller LE, Block JE (2013) Conservative management of symptomatic knee osteoarthritis: a flawed strategy. Orthop Rev (Pavia) 5(1):e2CrossRef

de Girolamo L, Kon E, Filardo G et al (2016) Regenerative approaches for the treatment of early OA. Knee Surg Sports Traumatol Arthrosc 24:1826–1835PubMedCrossRef

Carstairs A, Genever P (2014) Stem cell treatment for musculoskeletal disease. Curr Opin Pharmacol 16:1–6PubMedCrossRef

Freitag J, Bates D, Boyd R et al (2016) Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy—a review. BMC Musculoskelet Disord 17:230PubMedPubMedCentralCrossRef

10.

Peeters CM, Leijs MJ, Reijman M et al (2013) Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage 21:1465–1473PubMedCrossRef

11.

Wei CC, Lin AB, Hung SC (2014) Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry. Cell Transplant 23:505–512PubMedCrossRef

12.

Pers YM, Ruiz M, Noël D et al (2015) Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage 23:2027–2035PubMedCrossRef

13.

Castro-Manrreza ME, Montesinos JJ (2015) Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J Immunol Res 2015:394917

14.

Turner L, Knoepfler P (2016) Selling Stem Cells in the USA: assessing the Direct-to-Consumer Industry. Cell Stem Cell 19:154–157PubMedCrossRef

15.

Koh YG, Choi YJ (2012) Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 19:902–907PubMedCrossRef

16.

Koh YG, Kwon OR, Kim YS et al (2014) Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 30:1453–1460PubMedCrossRef

17.

Saw KY, Anz A, Siew-Yoke JC et al (2013) Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy 29:684–694PubMedCrossRef

18.

Vega A, Martín-Ferrero MA, Del CF et al (2015) Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation 99:1681–1690PubMedCrossRef

19.

Wong KL, Lee KB, Tai BC et al (2013) Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy 29:2020–2028PubMedCrossRef

20.

Osborne H, Castricum A (2016) Change to Australasian College of Sport and Exercise Physicians-position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med 50:1229PubMedCrossRef

21.

Yubo M, Yanyan L, Li L et al (2017) Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: a meta-analysis. PLoS One 12:e0175449PubMedPubMedCentralCrossRef

22.

Cui GH, Wang YY, Li CJ et al (2016) Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: a meta-analysis. Exp Ther Med 12:3390–3400PubMedPubMedCentralCrossRef

23.

Xia P, Wang X, Lin Q et al (2015) Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop 39:2363–2372PubMedCrossRef

24.

Pas HI, Winters M, Haisma HJ et al (2017) Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med 51:1125–1133PubMedCrossRef

25.

Filardo G, Perdisa F, Roffi A, Marcacci M, Kon E (2016) Stem cells in articular cartilage regeneration. J Orthop Surg Res 11:42PubMedPubMedCentralCrossRef

26.

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700PubMedPubMedCentralCrossRef

27.

Robinson KA, Chou R, Berkman ND et al (2016) Twelve recommendations for integrating existing systematic reviews into new reviews: EPC guidance. J Clin Epidemiol 70:38–44PubMedCrossRef

28.

Shea BJ, Grimshaw JM, Wells GA et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:10PubMedPubMedCentralCrossRef

29.

Shea BJ, Bouter LM, Peterson J et al (2007) External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One 2(12):e1350PubMedPubMedCentralCrossRef

30.

Jadad AR, Cook DJ, Browman GP (1997) A guide to interpreting discordant systematic reviews. CMAJ 156(10):1411–1416PubMedPubMedCentral

31.

Whiting P, Savović J, Higgins JP et al (2016) ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol 69:225–234PubMedPubMedCentralCrossRef

32.

Lewin S, Glenton C, Munthe-Kaas H et al (2015) Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med 12:e1001895PubMedPubMedCentralCrossRef

33.

Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–394PubMedCrossRef

34.

Carstensen K, Lou S, Groth JL et al (2017) Psychiatric service users’ experiences of emergency departments: a CERQual review of qualitative studies. Nord J Psychiatry 71:315–323PubMedCrossRef

35.

Young D (2005) Policymakers, experts review evidence-based medicine. Am J Health Syst Pharm 62(4):342–343PubMed

36.

Kristjánsson B, Honsawek S (2014) Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int 2014:194318

37.

Bekkers JE, Bartels LW, Benink RJ, Tsuchida AI, Vincken KL, Dhert WJ et al (2013) Delayed gadolinium enhanced MRI of cartilage (dGEMRIC) can be effectively applied for longitudinal cohort evaluation of articular cartilage regeneration. Osteoarthritis Cartil 21:943–949CrossRef

38.

Tan YH, Jiang MM, Yu HY et al (2013) Therapeutic effect of arthroscopy combined with autologous bone marrow stem cell grafting on knee osteoarthritis. J Trad 25(10):35–38

39.

Nejadnik H, Hui JH, Feng CEP et al (2010) Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 38(6):1110–1116PubMedCrossRef

40.

Vangsness CT, Farr J, Boyd J et al (2014) Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am 96(2):90–98PubMedCrossRef

41.

Akgun I, Unlu MC, Erdal OA et al (2015) Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg 135(2):251–263PubMedCrossRef

42.

Liang HS, Huang K, Lin L et al (2015) Arthroscopic microfracture surgery combined with autologous bone marrow mesenchymal stem cells transplant in the treatment of knee cartilage defect. Chin J Mod Drug App 9(9):1–3

43.

Lv XX, Huang C, Yin Z et al (2015) Effectiveness of autologous bone marrow mesenchymal stem cell transplant for knee osteoarthritis. Chin J Cell Stem Cell 5(2):28–32

44.

Varma HS, Dadarya B, Vidyarthi A (2010) The new avenues in the management of osteo-arthritis of knee--stem cells. J Indian Med Assoc 108(9):583–585PubMed

45.

Orozco L, Munar A, Soler R et al (2014) Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation 97(11):e66–e68PubMedCrossRef

46.

Gan FY, Tang C, Guo DB et al (2014) The treatment of mesenchymal stem cell transplantation for knee osteoarthritis: a clinical observation study. Modern Diagn Treat 1(15):3512–3513

47.

Davatchi F, Sadeghi AB, Mohyeddin M et al (2016) Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis 19:219–225PubMedCrossRef

48.

Emadedin M, Aghdami N, Taghiyar L et al (2012) Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 15(7):422–428PubMed

49.

Koh YG, Jo SB, Kwon OR et al (2013) Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 29(4):748–755PubMedCrossRef

50.

Buda R, Vannini F, Cavallo M et al (2010) Osteochondral lesions of the knee: a new one-step repair technique with bone-marrow-derived cells. J Bone Joint Surg Am 92 Suppl 2:2–11PubMedCrossRef

51.

Gobbi A, Karnatzikos G, Scotti C et al (2011) One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-year follow-up. Cartilage 2(3):286–299PubMedPubMedCentralCrossRef

52.

Turajane T, Chaweewannakorn U, Larbpaiboonpong V et al (2013) Combination of intra-articular autologous activated peripheral blood stem cells with growth factor addition/ preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation Improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease. J Med Assoc Thai 96(5):580–588PubMed

53.

Orozco L, Munar A, Soler R et al (2013) Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation 95(12):1535–1541PubMedCrossRef

54.

Kim JD, Lee GW, Jung GH et al (2014) Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol 24(8):1505–1511PubMedCrossRef

55.

Koh YG, Choi YJ, Kwon SK et al (2015) Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 23(5):1308–1316PubMedCrossRef

56.

Gobbi A, Karnatzikos G, Sankineani SR (2014) One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee. Am J Sports Med 42(3):648–657PubMedCrossRef

57.

Jo CH, Lee YG, Shin WH et al (2014) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells 32(5):1254–1266PubMedCrossRef

58.

Kim YS, Choi YJ, Suh DS et al (2015) Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold. Am J Sports Med 43(1):176–185PubMedCrossRef

Titel: Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview
verfasst von: Dan Xing
Qi Wang
Ziyi Yang
Yunfei Hou
Wei Zhang
Yaolong Chen
Jianhao Lin
Publikationsdatum: 22.12.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 8/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-017-3906-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2018

Lupus retinopathy: a marker of active systemic lupus erythematosus

HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study

The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?

Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs

Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials